Mesenchymal stromal cells for treatment of steroid-refractory GvHD: a review of the literature and two pediatric cases.
about
Cell therapy product administration and safety: data capture and analysis from the Production Assistance for Cellular Therapies (PACT) program.The interaction between mesenchymal stem cells and steroids during inflammation.Mesenchymal stem cell therapy and acute graft-versus-host disease: a review.Challenges and opportunities for international cooperative studies in pediatric hematopoeitic cell transplantation: priorities of the Westhafen Intercontinental Group.Comparison of biological characteristics of mesenchymal stem cells derived from maternal-origin placenta and Wharton's jelly.Mesenchymal stem cells as a novel vaccine platform.Identity, proliferation capacity, genomic stability and novel senescence markers of mesenchymal stem cells isolated from low volume of human bone marrow.Treatment of severe steroid resistant acute GVHD with mesenchymal stromal cells (MSC).Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessment.Mesenchymal stem cells for systemic therapy: shotgun approach or magic bullets?The possible diagnostic and prognostic use of systemic chemokine profiles in clinical medicine—the experience in acute myeloid leukemia from disease development and diagnosis via conventional chemotherapy to allogeneic stem cell transplantation.Could mesenchymal stromal cells have a role in childhood autoimmune diseases?Adult adherent stromal cells in the management of graft-versus-host disease.Mesenchymal stromal cells in the antimicrobial host response of hematopoietic stem cell recipients with graft-versus-host disease--friends or foes?Mesenchymal stem cell therapy for immune-modulation: the donor, the recipient, and the drugs in-between.The gap between the physiological and therapeutic roles of mesenchymal stem cells.Acute graft-versus-host disease following simultaneous pancreas-kidney transplantation: report of a case.Insurance approval of mesenchymal stem cell for acute GVHD in Japan: need of follow up for some remaining concerns.The potential of cytotherapeutics in hematologic reconstitution and in the treatment and prophylaxis of graft-versus-host disease. Chapter II: emerging transformational cytotherapies.Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety.Unrelated allogeneic bone marrow-derived mesenchymal stem cells for steroid-refractory acute graft-versus-host disease: a phase I/II study.Effects and safety of allogenic mesenchymal stem cell intravenous infusion in active ankylosing spondylitis patients who failed NSAIDs: a 20-week clinical trial.
P2860
Q30860263-2C0435B6-7E9E-47EF-98AB-902A2958DF83Q33695051-80EDBD38-5EE8-44A4-8B90-D0290C563439Q34294935-DC50BF2B-F69F-4E6D-AEF4-6C91F2125F0BQ34343785-E561CD8E-150C-4963-89FD-264CCB0FCF88Q36321598-4D1D8F66-7C59-4149-8474-1A468216D4EBQ36404011-4D20AF10-B40A-4867-A340-07FEFEDDDA13Q36998092-F0571B5E-6E0E-437E-94E3-DA9B8E73581EQ37127527-326835F3-9FDD-4CD1-BE2B-084EC8C968ABQ37323038-FD56D102-6BDE-48DA-814C-B929CFB6AE2DQ38062875-263BBC9E-750E-4F28-B85E-E7A44C307047Q38083604-65EE02E1-3174-408D-9D8D-90AA1F95E4E0Q38134131-B3641A0D-1E9B-4FEB-8D1D-053A53826661Q38176442-E61BAB70-F5C0-457F-8811-EAF592AD5B11Q38206879-078D3A22-BD17-44C0-9872-90F44C9270B2Q38215116-5149F440-1947-4894-AF8E-89CA6C67DB17Q38215374-1A800E39-E5BB-426E-BD79-43AA38BF6D45Q38265362-F8BBE9BE-45AB-4B51-8532-E995BAB5609CQ38694213-468488C0-BD83-49A3-82D0-1DCB36ED6ADEQ39012031-035C51C8-9225-43C4-8D9A-E83D94477136Q42593149-978CC813-DC1B-4E27-8357-32F9DF3FD822Q44268056-9557CE32-A532-4C3D-A987-7B06370E8C33Q50957540-E010E10F-16D9-4DAC-978F-DDCA704186FA
P2860
Mesenchymal stromal cells for treatment of steroid-refractory GvHD: a review of the literature and two pediatric cases.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Mesenchymal stromal cells for ...... ature and two pediatric cases.
@ast
Mesenchymal stromal cells for ...... ature and two pediatric cases.
@en
type
label
Mesenchymal stromal cells for ...... ature and two pediatric cases.
@ast
Mesenchymal stromal cells for ...... ature and two pediatric cases.
@en
prefLabel
Mesenchymal stromal cells for ...... ature and two pediatric cases.
@ast
Mesenchymal stromal cells for ...... ature and two pediatric cases.
@en
P2093
P2860
P356
P1476
Mesenchymal stromal cells for ...... rature and two pediatric cases
@en
P2093
Anita Lawitschka
Caroline M Wernicke
Christina Peters
Hans-Jochem Kolb
Ingo Mueller
Irene von Luettichau
Juenger Hendrik
Michaela Doering
Peter Bader
Selim Kuci
P2860
P356
10.1186/1755-7682-4-27
P407
P577
2011-08-15T00:00:00Z